Adamts13

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 02.04.2021

Dieser Artikel auf Deutsch

Synonym(s)

ADAMTS 13; ADAMTS-13; A disintegrin and metalloprotease with thrombospondin-1-like domains

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acronym for "A disintegrin and metalloprotease with thrombospondin-1-like domains". The corresponding ADAMTS 13 gene is located on chromosome 9 q34. The ADAMTS 13 protein is a member of a large family of zinc-containing metalloproteases, of which 20 members have now been described. They are involved in a number of different biological processes, such as connective tissue organization, inflammatory processes, arthritis, angiogenesis and cell migration. ADAMTS 13 cleaves von Willebrand factor (vWF).

General informationThis section has been translated automatically.

ADAMTS-13 cleaves the vWF multimer into smaller segments and thereby prevents the formation of larger aggregates (UL-vWF). Decreased activity of ADAMTS13 (<5-10%) results in high levels of UL-vWF in the blood plasma, leading to spontaneous platelet activation. These thrombi consist of large Von Willebrand factor complexes as well as activated platelets. The thrombotic vascular occlusions result in ischemia of downstream tissues(in the skin, necrotizing purpura).

Severely decreased activity (< 5-10%) of protease is specific for thrombocytic-thrombocytopenic purpura (M31 .1).

In secondary forms, ADAMTS13 is unremarkable or slightly decreased.

In the relatively common autoimmunologically (antibody formation) acquired form, ADAMTS13 antibodies are detectable.

Note(s)This section has been translated automatically.

Furthermore, a homologous protein subfamily was identified, the ADAMTS-like proteins, which do not have enzymatic functions. Of these, the ADAMTS-like protein 5 was identified as an autoantigen of melanocytes. It seems to play a role in the pathogenesis of psoriasis.

LiteratureThis section has been translated automatically.

  1. Mariotte E et al (2016) French Reference Center for Thrombotic Microangiopathies. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol 3:e237-245.
  2. Prince JC (2016) Autoimmune reactions in psoriasis. Dermatologist 67: 432-437
  3. Tersteeg C et al (2016) ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombocytopenic purpura - current perspectives and new treatment strategies. Expert Rev Hematol 9: 209-221.
  4. Thomas MR et al (2015) Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombocytopenic purpura. EBioMedicine. 2: 940-950.

Authors

Last updated on: 02.04.2021